Does adding magnetic stimulation to robot-assisted walking training improve leg stiffness and walking in people after stroke?

Effect of high-induction magnetic therapy (HIMT) combined with robot-assisted gait training (RAGT) versus standard physiotherapy on lower-limb spasticity and gait in chronic post-stroke patients: a single-centre, quasi-randomised, parallel-group interventional study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN63628238

Enrollment

Registered

2026-08-03

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic hemiparesis following ischaemic or haemorrhagic stroke

Interventions

Allocation to groups was done based on parity of the last digit of the birth number. Intervention group: High-induction magnetic therapy (HIMT) delivered to the affected lower limb, followed by robo

application time 9 minutes per session

stimulation intensity individually titrated in the range 60–80 % of maximum device output

sequence mode

6 sequences per session. Applicator placed over m. rectus femoris and m. triceps surae of the affected limb. HIMT dosing schedule: 15 sessions total. During the first one to two weeks preceding RAGT,

session duration tailored to the patient's physical capacity with a 45-minute organisational upper limit

parameters comparable across both arms. Control group: Usual rehabilitation with RAGT without HIMT

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Adults =18 years 2. Ischaemic or haemorrhagic stroke, confirmed by imaging, =6 months prior to enrolment (chronic stage) 3. Unilateral spastic hemiparesis with MAS =1+ in at least one lower-limb muscle group 4. Ability to stand and take at least a few steps with assistance (Functional Ambulation Category =2) 5. Cognitive status sufficient to follow instructions (MMSE =24 or equivalent clinical judgement) 6. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Contraindications to magnetic stimulation: implanted electronic devices (pacemaker, defibrillator, neurostimulator, cochlear implant), ferromagnetic implants in the treated region, pregnancy, active epilepsy 2. Contraindications to robotic gait training: severe orthopaedic instability of the lower limb, active pressure sores in weight-bearing areas, uncontrolled cardiovascular disease 3. Botulinum toxin administration to the treated limb <3 months prior to enrolment 4. Progressive neurological disease other than stroke 5. Severe cognitive or communicative impairment precluding testing

Design outcomes

Primary

Measure	Time frame
Mobility - functional mobility integrating gait speed, dynamic balance and transfer capacity measured using Timed Up-and-Go test (TUG), in seconds at baseline (T0) and immediately after completion of the 4-week programme (T1);Spasticity - knee extensors and plantar flexors of the affected limb measured using Modified Ashworth Scale (MAS) at baseline (T0) and immediately after completion of the 4-6-weeks programme (T1)	—

Measure

Time frame

Mobility - functional mobility integrating gait speed, dynamic balance and transfer capacity measured using Timed Up-and-Go test (TUG), in seconds at baseline (T0) and immediately after completion of the 4-week programme (T1);Spasticity - knee extensors and plantar flexors of the affected limb measured using Modified Ashworth Scale (MAS) at baseline (T0) and immediately after completion of the 4-6-weeks programme (T1)

—

Countries

Czech Republic

Contacts

Public ContactAleš Príhoda

ales.prihoda@fbmi.cvut.cz+420224357948

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Sep 19, 2026